PADMAJAMAHESHBABU

CADILAHC INVERSE HEAD AND SHOULDER

PADMAJAMAHESHBABU Updated   
NSE:CADILAHC   None


Cadila nod for clinical trials of Covid-19 vaccine.
The company has completed pre clinical development and plans to begin the trials in July 2020.

BEARISH ENGULFING FORMED IN HOURLY CHART.

TRADE ACCORDING TO YOUR ANALYSIS.
Comment:
TRADE ACHIEVED THE TARGET................
Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.